News

Charlie English delves into the CIA's attempts to combat communism via literature including '1984' in a book that reminds, in an age of book bans, how powerful stories — and reading — can be.
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific ...
--Wave Life Sciences Ltd., a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the presentation of ...
The analysis included 1,563 oral ASCO presentations, including 1,242 oral abstracts, 277 rapid oral abstracts and 44 plenary presentations. The 1,310 speakers represented 491 institutions.
2025 ASCO |Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer ...
BETHESDA, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and ...
SAN DIEGO and TOKYO, May 22, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, "Kura”) and Kyowa Kirin Co., Ltd. (TSE: 4151, "Kyowa Kirin”) today announced that an abstract highlighting the ...
In addition to the oral presentation, a trial-in-progress abstract for the KOMET-015 trial has been accepted for poster presentation on May 31, 2025.
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting ...
TOKYO -- With the rapid expansion of generative AI, tasks like translating English to Japanese or writing compositions have become easier than ever. B ...
Review: The NAC English Theatre's Presentation of the Epic MAHABHARATA: KARMA - PART 1 I implore you not to be put off by the fact that the play is in two parts. After you have seen Part 1, you ...
The oral presentation at EHA will include updated safety, complete remission, minimal residual disease (MRD) clinical findings, and longer duration of follow-up.